Skip to main content

BlackRock Inc.

SEC CIK
0001364742
Latest filing
Aug 13, 2024

NRXP holding history

NRX Pharmaceuticals, Inc. in every 13F filed by BlackRock Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRXP overviewAll 13F holders of NRXPFull Q2 2024 holdings

Shares (Q2 2024)
29,075
Value
$70.9K
% of portfolio
<0.1%
Quarters held
11
Since Q4 2021
Holdings of NRXP by BlackRock Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202429,075$70.9K<0.1%−261,639−90.0%ReducedHolders
Q1 2024290,714$137.2K<0.1%00.0%UnchangedHolders
Q4 2023290,714$133.7K<0.1%00.0%UnchangedHolders
Q3 2023290,714$75.6K<0.1%00.0%UnchangedHolders
Q2 2023290,714$140.6K<0.1%−84,533−22.5%ReducedHolders
Q1 2023375,247$247.3K<0.1%+2,718+0.7%AddedHolders
Q4 2022372,529$413.5K<0.1%−276,009−42.6%ReducedHolders
Q3 2022648,538$480.0K<0.1%−3,777−0.6%ReducedHolders
Q2 2022652,315$391.0K<0.1%+126,822+24.1%AddedHolders
Q1 2022525,493$1.29M<0.1%+10,045+1.9%AddedHolders
Q4 2021515,448$2.46M<0.1%+515,448NewHolders